Integrated Contract Development & Manufacturing backed by a validated, commercialization-ready API portfolio — built for global pharmaceutical companies.
Evaluate Your MoleculeAccelerate Your Market Entry
Skanttr Life Science offers integrated CDMO and CMO services backed by a ready technology portfolio. By partnering with us, global pharmaceutical companies gain a technically robust, commercially stable, and strategically aligned manufacturing partner in India.
We ensure seamless execution across every stage — from initial pilot batches to full commercial production.
What We Offer
API Portfolio
Our ready technology pipeline spans multiple therapeutic segments, each backed by validated process parameters and a defined impurity profile.
Confidential Portfolio: Complete API technology portfolio is shared under CDA/NDA due to commercial sensitivity. Contact our team to initiate a confidential discussion.
How We Work Together
We support structured collaboration formats designed to ensure sustainability for both partners — from single-molecule supply to long-term strategic alliances.
Dedicated capacity for your API manufacturing requirements with GMP-compliant systems and full documentation support.
Seamless transfer of your existing process into our facility with validated scale-up and continuity protocols.
Geography-locked exclusivity arrangements tailored to market access strategies and regulatory jurisdictions.
Multi-year supply frameworks with capacity reservation, pricing stability, and dedicated account management.
Tiered commercial structures linked to purchase volume commitments — optimizing unit economics for both parties.
Have a unique requirement? Our commercial structures are flexible. Let's discuss your project.
Our Commitment
We operate not merely as a supplier — but as an extension of your manufacturing strategy.
Over 100 technologies ready to transfer — reducing your time-to-market without early-stage development risk.
Manufacturing routes engineered for cost efficiency and yield performance at commercial scale.
WHO-GMP compliant infrastructure with full documentation, change control, and regulatory support.
Regular project updates, clear escalation paths, and dedicated account management for every partner.
Stable infrastructure, redundant sourcing, and on-time delivery execution in every commercial contract.
CDA/NDA-protected project handling from day one — your IP and commercial strategy remain protected.
Our Mission
Our objective is to enable pharmaceutical companies to scale without capital-intensive infrastructure investment — while maintaining consistent quality performance and strategic alignment.
If you are seeking a reliable API manufacturing partner for contractual production or technology collaboration, our team is ready to assess your project.


WhatsApp us